Persistence Capital Partners has made a “significant” investment in mdBriefCase, a Canadian and Australian provider of online continuing health education. No financial terms were disclosed.
TORONTO, Jan. 12, 2015 /PRNewswire/ – Persistence Capital Partners (“PCP”) is pleased to announce a significant equity investment in Canada and Australia’s leading provider of online continuing health education, mdBriefCase Group Inc. (“mdBriefCase”).
Founded in 2001, mdBriefCase provides continuing health and medical education programs for pharmacists, nurses, family physicians, specialists and patients. Providing free, multimedia interactive learning programs, mdBriefCase is a primary source of accredited continuing education for thousands of healthcare professionals. Its high quality programs are accredited by mdBriefCase’s leading medical institutional and organizational partners. Headquartered in Toronto, Canada with significant operations in Sydney, Australia, mdBriefCase has a team of over 40 employees.
John Trang, Principal at PCP, a private equity fund exclusively focused on growth and buyout opportunities in Canadian healthcare, said, “We are thrilled to support and partner with mdBriefCase. They lead the way in providing quality education programs for healthcare professionals and patients. The team at mdBriefCase has built a truly unique place to get up-to-date education on the latest healthcare topics, while providing its users with a convenient and innovative platform that meets the needs of busy healthcare professionals and patients.”
“Our partnership with PCP will help to strengthen our position as the leading provider in online health education programs and accelerate our expansion into new markets, technologies and geographies.” said Greg Cook, Founder and Chief Executive Officer at mdBriefCase. “Dan Denomme, President of mdBriefCase, Canada, and Derek Bryan, Managing Director, Australia, will continue to be an integral part of our growth strategy, leading their respective teams and servicing our valued clients.”
Dan Denomme, President of mdBriefCase Canada, added, “We are proud that PCP has recognized our success as a company, as well as the value of our programs and services. Along with our strong team and partners, we will continue to provide current, innovative and informative programs to over 125,000 members.”
Stuart M. Elman, Managing Partner at PCP, said, “Working with proven management teams, while bringing PCP’s deep industry knowledge, experience and relationships, is core to our successful investment strategy. mdBriefCase is our fifth platform investment in our latest fund, and we are excited to welcome mdBriefCase into our portfolio of companies.”
mdBriefCase Group Inc.
mdBriefCase Group Inc. is Canada and Australia’s foremost online continuing health and medical education provider. mdBriefCase provides free, multimedia interactive learning programs for physicians, specialists, pharmacists and allied healthcare professionals such as nurses, diabetes educators, etc. Its accredited and non-accredited programs are written by the leading specialists in their respective fields and developed by prestigious educational institutions.
mdBriefCase has a family of websites with various offerings and objectives for different audiences and interests. Today, mdBriefCase provides accredited education programs through several online platforms including www.mdBriefCase.com, www.mdBriefCase.com.au, www.AdvancingIn.com, www.AdvancingPractice.com, and www.rxBriefCase.com. Non-accredited education programs can be found at www.mdPassport.com, www.rxPassport.ca, and www.medschoolforyou.ca.
Founded in 2001, mdBriefCase is headquartered in Toronto, Canada, with significant operations in Sydney, Australia. mdBriefCase is a full service online company with design, programming, email, database and project management capabilities.
About Persistence Capital Partners
Persistence Capital Partners is a private equity fund exclusively focused on high-growth opportunities in the healthcare field. With deep healthcare industry expertise, PCP aims to create significant long-term capital appreciation for its investors by identifying and developing attractive investment opportunities in the Canadian healthcare market.